Pro-Pharmaceuticals, Inc. (PRW) to Hold Conference Call to Provide Update Following Company’s Annual Meeting of Stockholders
5/26/2011 11:35:49 AM
More...
|
Pro-Pharmaceuticals, Inc. (PRW) Changes Company Name to Galectin Therapeutics
5/26/2011 11:07:41 AM
More...
|
Pro-Pharmaceuticals, Inc. (PRW) to Hold Conference Call to Provide Update Following Company’s Annual Meeting of Stockholders
5/20/2011 8:30:17 AM
More...
|
Pro-Pharmaceuticals, Inc. (PRW) Reports First Quarter 2011 Financial Results
5/13/2011 10:38:40 AM
More...
|
Pro-Pharmaceuticals, Inc. (PRW)' Presentation at Noble Financial Capital Markets' Seventh Annual Equity Conference to Be Webcast Live
5/10/2011 10:28:27 AM
More...
|
Pro-Pharmaceuticals, Inc. (PRW) Selects SAFC to Ramp-up the Manufacture of DAVANAT(R) for Anticipated Use in Clinical Trials & Sales in Colombia
5/3/2011 11:24:57 AM
More...
|
Pro-Pharmaceuticals, Inc. (PRW) Expands Patent Coverage to Japan
4/25/2011 8:33:12 AM
More...
|
Ludwig Institute For Cancer Research (LICR) and Pro-Pharmaceuticals, Inc. (PRW) Discover That DAVANAT(R) Enhances the Ability of Anti-Tumor T Lymphocytes to Kill Tumor Cells
4/20/2011 8:45:23 AM
More...
|
Pro-Pharmaceuticals, Inc. (PRW) Expands Patent Portfolio with New Patents in the U.S. and Australia
3/22/2011 9:09:50 AM
More...
|
Pro-Pharmaceuticals, Inc. (PRW) Reports Full Year and Fourth Quarter 2010 Financial Results
3/15/2011 9:52:48 AM
More...
|
|